The primary goal is to examine the efficacy and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Uzbekistan.
Study Type
OBSERVATIONAL
Enrollment
135
Bukhara Maternity House No. 1
Bukhara, Uzbekistan
Samarkand Perinatal Center
Samarkand, Uzbekistan
Clinic No. 2, Tashkent Medical Academy
Tashkent, Uzbekistan
Proportion of abortions that are complete as a measure of efficacy
It is a proportion that specifies how many abortions out of all initiated abortions are complete without recourse to surgical intervention within 15 hours after the start of misoprostol administration.
Time frame: At 15 hours after the start of misoprostol administration
Interval of time between induction with misoprostol to complete abortion
It is the length of time between the administration of the first dose of misoprostol and complete abortion.
Time frame: Every 3 hours from the start of misoprostol administration until complete abortion
Women's satisfaction with the method
It is a scale that assesses the level of a woman's satisfaction with the procedure.
Time frame: At discharge, up to 5 days after enrollment
Side effects experienced by women
It is a brief questionnaire that records all side effects experienced by women.
Time frame: Every 3 hours from the start of misoprostol administration until complete abortion
Pain experienced by women
It is a scale that assesses the acceptability of pain experienced by the woman.
Time frame: At the time of discharge, up to 5 days after enrollment
Complications during induction and after discharge
It is a record of complications and their treatment during induction and up to 1 month after discharge.
Time frame: Every 3 hours from the start of misoprostol administration, up to 1 month after discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Women's perception of acceptability of the procedure
It is a scale that assesses the acceptability of the procedure for the woman.
Time frame: At discharge, up to 5 days after enrollment
Provider's perception of acceptability of the method
It is a questionnaire that assesses the acceptability of the method for the provider.
Time frame: At study completion, up to 2 years after study enrollment commences
Total dose of misoprostol administered
Count of the total dose of misoprostol administered from the first dose to complete abortion.
Time frame: Every 3 hours from start of misoprostol administration to complete abortion